![Allogene Therapeutics Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/allo.png?tr=w-200)
Allogene Therapeutics Inc
NASDAQ:ALLO
![Allogene Therapeutics Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/allo.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/allo.png)
Allogene Therapeutics Inc
Depreciation & Amortization
Allogene Therapeutics Inc
Depreciation & Amortization Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/gild.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/amgn.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/vrtx.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/regn.png)
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Allogene Therapeutics Inc
NASDAQ:ALLO
|
Depreciation & Amortization
$14.2m
|
CAGR 3-Years
24%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
![]() |
Abbvie Inc
NYSE:ABBV
|
Depreciation & Amortization
$8.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
37%
|
CAGR 10-Years
26%
|
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
Depreciation & Amortization
$2.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
14%
|
CAGR 10-Years
18%
|
![]() |
Amgen Inc
NASDAQ:AMGN
|
Depreciation & Amortization
$4.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
12%
|
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Depreciation & Amortization
$196m
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
14%
|
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Depreciation & Amortization
$435.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
26%
|
See Also
What is Allogene Therapeutics Inc's Depreciation & Amortization?
Depreciation & Amortization
14.2m
USD
Based on the financial report for Mar 31, 2024, Allogene Therapeutics Inc's Depreciation & Amortization amounts to 14.2m USD.
What is Allogene Therapeutics Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
45%
Over the last year, the Depreciation & Amortization growth was 1%. The average annual Depreciation & Amortization growth rates for Allogene Therapeutics Inc have been 24% over the past three years , 45% over the past five years .